HealthcareServices

Anemia In Elderly Market Anticipated to Record Steady Gains, Advancing to $4.59 Billion by 2030

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the anemia in elderly market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Anemia In Elderly Market covering 2026–2035?

The anemia in elderly market size has shown significant expansion in recent years. It is expected to rise from $2.99 billion in 2025 to $3.26 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. The historical growth in this market can be linked to factors such as an expanding aging population, an increased occurrence of chronic diseases, the presence of oral iron supplements, the broadening of hospital-based anemia treatment, and a growing understanding of nutritional deficiencies.

The market size for anemia in elderly individuals is anticipated to experience robust growth in the coming years, projected to reach $4.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This projected growth is largely due to factors such as an increasing demand for customized anemia treatments, the wider adoption of long-acting injectable medications, a heightened focus on geriatric healthcare services, the expansion of outpatient options for anemia management, and improvements in diagnostic screening practices within elderly care. Significant trends expected during this forecast period include a growing preference for combination therapy approaches, an increase in the utilization of injectable iron treatments, a stronger emphasis on early diagnosis among elderly populations, the development of more home-based treatment alternatives, and a reinforced commitment to managing anemia associated with chronic diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Anemia In Elderly Market?

The escalating elderly population is projected to stimulate the expansion of the anemia in the elderly market in the coming years. This demographic represents the growing number and proportion of individuals aged 65 and older, either within a particular society or globally. The increase in the elderly population can be attributed to factors such as extended life expectancy, declining birth rates, and the aging of large generational cohorts. An expanding elderly population leads to a greater prevalence of age-related and chronic health issues, which are significant causes of anemia in older adults. This, in turn, fuels the demand for the diagnosis, management, and treatment of anemia, thereby boosting market growth. For instance, in January 2024, as reported by the Population Reference Bureau, a Kenya-based Nonprofit organization, the population of Americans aged 65 and older is anticipated to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. This age group’s representation within the overall population is also expected to climb from 17% to 23% during the same period. Consequently, the increasing elderly population is driving the growth of the anemia in the elderly market.

What Leading Segments Are Studied In The Anemia In Elderly Market?

The anemia in elderly market covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections

What Trends Are Driving The Growth Trajectory Of The Anemia In Elderly Market?

Companies specializing in the anemia in the elderly market are prioritizing technological advancements, such as customized therapies, to streamline treatment processes, improve patient outcomes, reduce side effects, and enhance overall healthcare efficiency. Individualized treatments are medical interventions based on each patient’s unique characteristics. For instance, in March 2024, Cadila Pharmaceuticals, an Indian-based pharmaceutical company, announced the launch of Redshot FCM, a novel iron injection designed to treat iron deficiency anemia for patients who cannot tolerate oral iron. This intravenous iron preparation delivers adequate amounts of iron and offers an excellent safety profile. The injection features an advanced Ferric Carboxymaltose formulation that improves iron delivery and absorption. Redshot FCM demonstrates a commitment to improving healthcare by developing personalized therapies that account for individual patient profiles, leading to better treatment outcomes for iron deficiency anemia.

Which Major Firms Are Strengthening Their Position In The Anemia In Elderly Market?

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Anemia In Elderly Market?

North America was the largest region in the anemia in elderly market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anemia In Elderly Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20711&type=smp

Browse Through More Reports Similar to the Global Anemia In Elderly Market 2026, By The Business Research Company

Anosmia Market Report 2026

https://www.thebusinessresearchcompany.com/report/anosmia-global-market-report

Chemotherapy Induced Anemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Aplastic Anemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/aplastic-anemia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795